# Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIG

> **NCT01137045** · PHASE4 · COMPLETED · sponsor: **Queen Saovabha Memorial Institute** · enrollment: 210 (actual)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** SPEEDA and TRCS SPEEDA

## Key facts

- **NCT ID:** NCT01137045
- **Lead sponsor:** Queen Saovabha Memorial Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01137045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01137045, "Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIG". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01137045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*